Teva- Pharmaceutical Industries Minority Interest

As of the most recent data (June 2026), TEVA shows a minority interest of $4M. That compares with $7M in the prior-year period — down 42.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, TEVA's minority interest is now $4M (was $7M) — a 42.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Teva- Pharmaceutical Industries is outperforming or lagging.

Tracking TEVA's minority interest over time shows whether Teva- Pharmaceutical Industries is scaling, shrinking, or reshaping that part of the business. The current reading is $4M That compares with $7M in the prior-year period — down 42.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Teva- Pharmaceutical Industries's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $4M) with ownership activity and broader fundamentals.

Teva- Pharmaceutical Industries's minority interest is $4M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.